AZ513
AZ513 is a reversible FAAH inhibitor with an IC50s of 551 nM and 27 nM for human FAAH and rat FAAH, respectively. AZ513 inhibits Anandamide hydrolysis in human FAAH-transfected HEK293 cells (IC50 of 360 nM).
Product Specifications
CAS Number
1335231-15-6
UNSPSC
12352005
Target
FAAH
Related Pathways
Metabolic Enzyme/Protease; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
O=C(C1=C(Cl)C(Cl)=CC=C1)NC2=CC3=C(NC=C3)N=C2
Molecular Formula
C14H9Cl2N3O
Molecular Weight
306.15
References & Citations
[1]Scott CW, et al. Biochemical characterization and in vitro activity of AZ513, a noncovalent, reversible, and noncompetitive inhibitor of fatty acid amide hydrolase. Eur J Pharmacol. 2011 Sep 30;667 (1-3) :74-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2997332-01 48 Tests
Human sIL30 (Soluble Interleukin 30) Microsample ELISA Kit
Sign In for Pricing
View Details orb2997332-02 96 Tests
Human sIL30 (Soluble Interleukin 30) Microsample ELISA Kit
Sign In for Pricing
View Details MBS6171009-01 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (Biotin)
Sign In for Pricing
View Details MBS6171009-02 5x 0.1 mL
MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (Biotin)
Sign In for Pricing
View Details